Natus Medical Incorporated (NTUS): Price and Financial Metrics


Natus Medical Incorporated (NTUS)

Today's Latest Price: $21.44 USD

0.01 (-0.05%)

Updated Nov 27 1:00pm

Add NTUS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

NTUS Stock Summary

  • The price/operating cash flow metric for Natus Medical Inc is higher than 82.07% of stocks in our set with a positive cash flow.
  • The ratio of debt to operating expenses for Natus Medical Inc is higher than it is for about just 23.47% of US stocks.
  • As for revenue growth, note that NTUS's revenue has grown -15.13% over the past 12 months; that beats the revenue growth of merely 23.15% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Natus Medical Inc, a group of peers worth examining would be PRCP, SCWX, NURO, SONM, and SYNC.
  • Visit NTUS's SEC page to see the company's official filings. To visit the company's web site, go to www.natus.com.

NTUS Stock Price Chart Interactive Chart >

Price chart for NTUS

NTUS Price/Volume Stats

Current price $21.44 52-week high $34.67
Prev. close $21.45 52-week low $16.38
Day low $21.20 Volume 63,900
Day high $21.59 Avg. volume 258,918
50-day MA $18.76 Dividend yield N/A
200-day MA $21.28 Market Cap 726.13M

Natus Medical Incorporated (NTUS) Company Bio


Natus Medical is a provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. The company was founded in 1987 and is based in Pleasanton, California.


NTUS Latest News Stream


Event/Time News Detail
Loading, please wait...

NTUS Latest Social Stream


Loading social stream, please wait...

View Full NTUS Social Stream

Latest NTUS News From Around the Web

Below are the latest news stories about Natus Medical Inc that investors may wish to consider to help them evaluate NTUS as an investment opportunity.

Natus Medical Incorporated (NTUS) CEO Jonathan Kennedy on Q2 2020 Results - Earnings Call Transcript

Natus Medical Incorporated (NTUS) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Jonathan Kennedy - President and Chief Executive Officer Drew Davies - Executive Vice President and Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond James Presentation Operator Good afternoon, everyone, and thank...

SA Transcripts on Seeking Alpha | August 2, 2020

Natus Medical Announces Second Quarter 2020 Financial Results

Q2-2020 Key Results Revenue (millions)$84.8 • Newborn Care revenue increased 1% compared to second quarter last year • Reduced debt by $13.0 million during the quarter  • NICVIEW II released during the quarter GAAP loss per share$0.26  Non-GAAP loss per share$0.13      PLEASANTON, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ:NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and six months ended June 30, 2020.For the second quarter ended June 30, 2020, the Company reported revenue of $84.8 million, a decrease of 32.4% compared to $125.5 million reported for ...

Yahoo | July 30, 2020

Did Hedge Funds Make The Right Call On Natus Medical Inc (NTUS)?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

Yahoo | July 17, 2020

Natus Medical to Hold 2020 Second Quarter Financial Results Conference Call on July 30th

Natus Medical Incorporated (NTUS), (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, announced today that the Company will release its 2020 second quarter financial results after the close of the market on Thursday, July 30th. Individuals interested in listening to the conference call may do so by dialing 1-844-634-1441 for domestic callers, or 1-508-637-5658 for international callers, and entering reservation code 1467486. A telephone replay will be available for 48 hours following the conclusion of the call by dialing 1-855-859-2056 for domestic callers, or 1-404-537-3406 for international callers, and entering reservation code 1467486.

Yahoo | July 2, 2020

Natus partners with Holberg EEG to advance the diagnosis of Epilepsy

Natus Medical Incorporated (NTUS) (the “Company” or “Natus”), a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, is excited to announce a partnership with Holberg EEG AS. The partnership will advance the development and distribution of an AutoSCORE algorithm to automate Electroencephalography (“EEG”) classifications and improve reporting efficiency. “We are excited about this new partnership,” said Jonathan Kennedy, Chief Executive Officer at Natus.

Yahoo | May 12, 2020

Read More 'NTUS' Stories Here

NTUS Price Returns

1-mo 17.74%
3-mo 18.06%
6-mo -2.10%
1-year -32.98%
3-year -46.47%
5-year -57.32%
YTD -35.01%
2019 -3.06%
2018 -10.92%
2017 9.77%
2016 -27.58%
2015 33.32%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8635 seconds.